D-Wave Quantum: A Backloaded Year Puts the Fourth Quarter in the Crosshairs
Published on 08/13/2026 at 10:31 | Redaktion boerse-global.de
The gap between what D-Wave Quantum is selling and what it is actually billing has rarely been wider. Bookings for the first half of fiscal 2026 exploded to $35.5 million, a 1,120% leap year over year, while the order backlog swelled 668% to $40.7 million. Yet the revenue line tells a far quieter story: just $3.1 million in quarterly sales, missing the $4.03 million analysts had penciled in.
That divergence is the central tension for anyone holding the stock. The company is either on the cusp of converting research-stage interest into genuine commercial traction, or it is stockpiling commitments that will take far longer to materialize than the market hopes.
Management has been unusually candid about the timing. According to company communications, the bulk of revenue expected for fiscal 2026 is slated to land in the fourth quarter. That is a remarkably transparent admission — and a pointed reminder that investors are effectively placing a bet on a single quarter's performance. The visibility problem is real: a company that cannot smooth its own revenue recognition across the year arguably deserves a discount relative to peers with steadier demand patterns.
The bookings surge is heavily concentrated. A single $20 million order from Florida Atlantic University accounts for a substantial portion of the jump — meaningful for a company of D-Wave's size, but also a signal that demand has yet to broaden across many independent customers.
A Fortified Balance Sheet Buys Time
The cash position offers breathing room. D-Wave held $546.2 million in cash as of June 30, 2026, and the per-share loss narrowed sharply from $0.55 to $0.13 year over year. That gives management runway to convert the backlog into recognized revenue without existential pressure — though it does not substitute for a credible, recurring sales trajectory.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Meanwhile, the company continues to stack up public-sector validation. The National Science Foundation awarded $1.57 million for the ERASE project, a fault-tolerant quantum computing initiative led by Yale University, in which D-Wave participates through its Quantum Circuits subsidiary and its superconducting dual-rail gate-model platform. A separate commitment of up to 300,000 Canadian dollars (roughly $299,000) from Canada's National Research Council will fund graph-minor embedding algorithms for the Zephyr topology and their integration into the open-source Ocean SDK, with work taking place at the Quantum Centre of Engineering Excellence in Burnaby. The goal is to tackle larger optimization problems on Advantage2 systems with more than 4,400 qubits across logistics, manufacturing, finance, machine learning, and quantum simulation.
Trevor Lanting, D-Wave's technology development lead, framed software innovation as essential to expanding the commercial impact of quantum computing — a telling sign that the company intends to differentiate itself through developer tools as much as hardware advances.
Add to that a non-binding letter of intent for $100 million under the CHIPS and Science Act, and the picture is clear: D-Wave is deliberately layering government support across both its established annealing business and its newer gate-model ambitions. These grants are affirmations of institutional confidence, not revenue drivers — but they signal that the company remains credible in the research funding ecosystem on both sides of the border.
What the Chart Says
The stock closed Wednesday in Germany at €17.96, up 2.5% on the day, and has gained 8.0% over the past month. Still, the shares remain roughly 21% below their level at the start of the year. The annualized volatility sits at a striking 105%, which explains why single headlines — like the grant announcements — can move the price so sharply.
The longer-term picture is equally volatile. At €18.16, the stock trades about 55% below its 52-week high of €40.41 from October 2025, yet roughly 63% above its late-March low. That range alone captures the whiplash between hype and disillusionment that has defined this name.
Wall Street remains constructive, with Wedbush at Outperform and a $40 price target, while Rosenblatt rates the stock a Buy with a $43 target. Cantor Fitzgerald is also cited with targets up to $40, and the consensus sits at "Moderate Buy." Those targets, however, rest on the assumption that the bookings boom eventually translates into recognized revenue — precisely the open question.
For now, D-Wave has the balance sheet to wait out the uncertainty. The real test arrives when the fourth quarter's numbers finally land.
Ad
D-Wave Quantum Stock: New Analysis - 13 August
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
